www.medgatetoday.com
PRICE :
100
Volume V || Issue I || May - June 2014
The Gateway to Health & Medical World
PainProblems Size of Prostate Could Indicate
Prof (Dr) Rajeev Sood
Opportunities in
Scan the QR Code to know more
Healthcare Management
News Update | Doctor Speak | Expert Views | Product Line | Interview | Healthcare Management
SMARTER DOCUMENT IMAGING With
Why is Document Imaging Important? Document imaging is the conversion of paper documents into electronic images on your computer. Once on your desktop, these documents can be retrieved effortlessly in seconds. Thousands of organizations around the world use document imaging every day instead of paper filing systems.
The Business Benefits are Obvious:
Common Challenges of Users:
Reduce the Risk of Losing Important Business Information
Time wasted in searching for misplaced or wrongly filed documents
Save Storage Space, Eliminate Need for File Cabinets
Issues in managing huge volume of documents
Find and Manage Records Easily
Document safety during disasters/accidents
Increase Productivity and Improve Customer Satisfaction
Issues in flexibility of easy retrieval of documents, especially when on the go
Capture Pro Software
Scanmate i940 Scanner
i2400 Scanner
Capture Pro Software
Storage space constraint
i2900 Scanner
Capture Pro Software
New Integrated Flatbed
Please contact Kodak Alaris India Pvt. Ltd. Toll free No: 1800228989 www.kodakalaris.com
i1420 Scanner
Capture Pro Software
i3000 Scanner
Capture Pro Software
i4000 Series Scanner
Capture Pro Software
Available at DGS&D contract rate
© 2014 Kodak Alaris India Pvt. Ltd.
The Kodak trademark and trade dress are used under license from Eastman Kodak Company.
Licensed Product
New Launch Foley Catheter
“Silkycath”
Manufacturing wide range of surgical blades and scalpels which made us India’s No.1 Skin Graft Blade and World’s 3rd Largest Variety of Surgical blade Manufacturing Company. We are exporting premium quality surgical blade and scalpels in 85 countries worldwide Now introducing complete Range of Foley catheter manufacturing in the world class clean Room and state of the art manufacturing facility
Manufacture By:
RIBBEL INTERNATIONAL LTD Our products are accredited by
20th Mile, Jatheri Road, P.O. RAI, Near Rai Industrial Area Sonepat Haryana 131029 Tel: +91 8053111016, 8053111011 Fax: +91 11-23264398 Email: sales@ribbel.com • www.ribbel.com
Editor’s note
The global infection control market will grow at a steady pace of around 6% from $10.5 billion in 2012 to $14.0 billion by 2017.
T
he rise in tide of cleaning standards and mounting pressure for sterilized and disinfected medical devices in hospitals and clinics has triggered the growth of medical sterilization and disinfection market. The increase in hospital acquired infections or nosocomial infections have forced the medical authorities to take stringent regulatory actions to curb these infections with the use of sterilized and disinfected medical devices. Gamma and E-beam types of sterilization services are poised to have better growth over EtO in the near future due to their wider application with respect to sterilization of food, pharmaceutical, medical devices, life sciences, and cosmetic products. Along with sterilization, cleaning and sanitation are also important activities carried out in healthcare, food, and pharmaceutical industry. Hand disinfectant market is the fastest growing segment as hands are considered to be the primary cause of cross infection. The demand for sanitizing and preservative disinfectants in food industry is also increasing due to high risks associated with foodborne pathogens along with other bacterial and viral food related infections. Increased focus on hygiene and spread of infections are the driving forces for disinfectants in the all the sectors. The endoscope reprocessing market is anticipated to show healthy growth in the near future due to continued instrument development and increasing minimally invasive surgery procedures. Riding on these factors, along with increasing usage of single-use technology products such as medical non-wovens and face masks, the global disinfection market is expected to grow at a CAGR of more than 6.0% from 2012 to 2017.
magazine Volume - V Issue - I May- June 2014
Editor Chief Editor Editorial Advisor
National Head Business Development Manager Asst. Manager Corporate Communication
Cheif Correspondent Design and Layout Sales and Marketing Subscribtion & Cirrculation
Dr. Pradeep Bhardawaj GP Capt. (Dr.) Sanjeev Sood Dr. Sharad Lakhotia Afzal Kamal Sunder Mewadi Sonia Pandit
SA Rizvi, Dr. HN Sharma Mohd. Javed Ahmad Amjad Kamal, SY Ahmed Khan, Ranjit Shirsath Jagruti Diddi, Saba Khan All right Reserved by all everts are made to insure that the information published is correct ‘Medgate today’ holds no responsibility any unlikely errors that might occur.
Published by
Advance Media Group Circulation Office: 92/17 Zakir Nagar, Opp. New Friends Colony, Okhla New Delhi - 110 025 Tel: +91 - 11 - 26981342 Fax: +91 - 11 - 26982464 M: +91 - 9212366351 Email: info@medgatetoday.com medgatetoday@gmail.com Visit us: www.medgatetoday.com
Mumbai Office
7 - Ground Floor, Aradhna CHS Ltd. Bal Samant Marg, Bandra (W), Mumbai-400 050
Chennai Office
11, Krishnan, Koil Street 3rd Floor Rotary Lane Chennai - 600001
Printed by
Artxel, 76, DSIDC Shed, Okhla Industrial Area Phase - II, New Delhi - 110020
Dr. Pradeep Bhardawaj Editor -in-Chief
Dr. ma Kamal
Have an insightful reading. Your suggestions are most welcome! E-mail: editor@medgatetoday.com Website: w w w . m e d g a t e t o d a y . c o m
6
Nov - Dec 2013
May - June 2014 Contents
Hitex Healthcare, Industry Expert...
Understanding & Treating Heart Failure
14
Commander Manoj Kumar (Retd)
Doctor Speak & Exper Views
CEO, Hitex Healthcare
Dr. Vishal Rastogi Sr. Consultant, Cardiology
32
Fortis Escort Heart Institute
Master of the Heart
36
Dr. Aparna Jaswal
Pediatricians a Caring Hand for Children
40
Dr. Rajiva Kumar Child Specialist Muzaffarpur Bihar
Sr. Cardiologist Fortis Escort Heart Institute
Pain size of Prostate Could Indicate... Prof (Dr) Rajeev Sood
42
Head of Dept. Urology RML Hospital
Brain Aneurysms what everyone needs... Clinical Fellow Dept. of Neurosurgery
46
Dr. Vanita Arora
Sr. Consultant Max Super Speciality Hospital
Opportunities in Healthcare Management
54
Dr. Sudheer Ambekar
Heart Attack is not Sudden Cardiac...
Prof. M. Habeeb Ghatala Dean for Non-medical Institutions, Apollo Health City
56
Ask a Question from Healthcare Industry...
Understanding & Treating Heart Failure
A Guide for Patients and Families
Dr. Pradeep Bhardwaj
58
CEO & Executive Director Six Sigma Healthcare Ltd.
NEWS
6 Cautious optimism for new... 8 Injecting new design 17 New Central Scanning ... 18 WHO’s first global report 20 zest2014 22 Medgatetoday & MFI jointly... 24 Medical Fair India 2014... 25 Integrating Virtual Reality...
32 Nov - Dec 2013
26 GE Healthcare & CTSI... 28 XVI National Seminar... 7
NEWS Update
Exanatide an alternative to insulin for type 2 patients
for new breast cancer drug An experimental inhibitor of cyclin-dependent kinases (CDK) 4 and 6 halves time to disease progression in women with hormone receptor positive metastatic breast cancer, researchers say.
For type 2 diabetes patients not controlled with oral hypoglycaemic drugs, exanatide may be an alternative to starting insulin treatment, three year findings from the DURATION-3 trial suggest.
Their phase 2 trial involved 165 women with advanced ER positive, HER2 negative breast cancer randomised to either letrozole plus CDK4/6 inhibitor palbociclib or to letrozole only.
A weekly injection of the long- acting GLP-1 receptor agonist provided better HbA1c control and also avoided weight gain and hypoglycaemic episodes seen with glargine insulin, according
However the study authors pointed out as only 61 of the 165 patients had died so far, statistical significance should not have been expected at this point in the trial and that data were trending in the right direction.
to study published in the Lancet Diabetes and Endocrinology.However, exanatide was less well tolerated than insulin, the study showed.In the DURATION-3 trial, 456 patients - including some from Australian centres with type 2 diabetes not controlled with oral drugs such as metformin and sulfonylureas were randomised to either a once-weekly SC injection of exanatide or once daily insulin glargine. 8
Cautious optimism
w w w . m e d e g a t e t o d a y. c o m
Presented yesterday at the annual meeting of the American Association for Cancer Research, the results showed those on palbociclib had a median time to disease progression of 20.2 months compared with 10.2 months with letrozole only. Overall survival was better in the palbociclib arm at 37.5 months compared with 33.3 months, but the difference failed to reach statistical significance.
The drug was generally well tolerated although adverse events included neutropenia, leukopenia, fatigue and anaemia.
RF ablation effective in Barrett’s with low-grade dysplasia Radiofrequency ablation (RFA) is far more effective than endoscopic surveillance at cutting the risk of progression to cancer in Barrett’s oesophagus with low-grade dysplasia, Dutch researchers find.In pathologist-confirmed lowgrade dysplasia, RFA cut the absolute risk of progression to high-grade dysplasia or adenocarcinoma within three years by a quarter compared with endoscopic surveillance (1.5% vs 26.5%),Absolute risk of progression to adenocarcinoma only was cut by 7.4% (1.5% vs 8.8%), the Amsterdam-based authors found. Complete eradication of dysplasia occurred in 93% of patients undergoing RFA compared with 28% of those in the surveillance arm, they said.Treatment-related adverse events occurred in a fifth of patients in the ablation group but these were mostly mild.The most common was oesophageal stricture, which resolved with a median of one endoscopic dilation. May - June 2014
NEWS Updat e
w w w . m e d e g a t e t o d a y. c o m
May - June 2014
9